CencoraRegister for a premium account to gain access to Sterling AI.
Get StartedThings you can ask Sterling:
CencoraPharmaceutical distributor formerly AmerisourceBergen, renamed in 2023. FY2025 revenue rose 9.3% to $321.3B, growth the company attributes largely to higher-priced new therapies including the GLP-1 class; US Healthcare Solutions revenue specifically cites diabetes and weight-loss labelled products.
Browse all official SEC filings including annual reports, quarterly updates, and material event disclosures.
SEC filings for this company are not available at the moment.